drugset / Trial / NCT00003252

Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy

NCT00003252

Supportive care

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Chemoprotective drugs, such as amifostine, may protect normal cells from the side effects of chemotherapy. PURPOSE: Phase IV trial to study the effectiveness of amifostine in treating patients with cancer who have neurological changes caused by chemotherapy.

Timeline

Start
1997-12
Primary completion
Completion
2004-09

Drugs

EvaluationDrugModalityDoseRoute
Subject amifostine Unknown Intravenous